It was reported that EMAST was associated with the loss of MSH3 nuclear expression in colorectal cancer [10], while no significant correlation between EMAST and loss of MSH3 expression was reported in pancreas cancer [11]. The gene discussed is MSH3; the disease is colorectal cancer.